FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

1074641000202107: Product containing precisely linagliptin 2.5 milligram and metformin hydrochloride 1 gram/1 each conventional release oral tablet (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Feb 2024. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
11777811000202115 Product containing precisely linagliptin 2.5 milligram and metformin hydrochloride 1 gram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
11793681000202111 Linagliptin 2.5 mg and metformin hydrochloride 1 g oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing precisely linagliptin 2.5 milligram and metformin hydrochloride 1 gram/1 each conventional release oral tablet (clinical drug) Is a Product containing only linagliptin and metformin in oral dose form (medicinal product form) true Inferred relationship Some
Product containing precisely linagliptin 2.5 milligram and metformin hydrochloride 1 gram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form Oral tablet true Inferred relationship Some
Product containing precisely linagliptin 2.5 milligram and metformin hydrochloride 1 gram/1 each conventional release oral tablet (clinical drug) Has unit of presentation Tablet (unit of presentation) true Inferred relationship Some
Product containing precisely linagliptin 2.5 milligram and metformin hydrochloride 1 gram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient Metformin hydrochloride true Inferred relationship Some 1
Product containing precisely linagliptin 2.5 milligram and metformin hydrochloride 1 gram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) Metformin hydrochloride true Inferred relationship Some 1
Product containing precisely linagliptin 2.5 milligram and metformin hydrochloride 1 gram/1 each conventional release oral tablet (clinical drug) Has presentation strength numerator unit g true Inferred relationship Some 1
Product containing precisely linagliptin 2.5 milligram and metformin hydrochloride 1 gram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Some 1
Product containing precisely linagliptin 2.5 milligram and metformin hydrochloride 1 gram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient Linagliptin (substance) true Inferred relationship Some 2
Product containing precisely linagliptin 2.5 milligram and metformin hydrochloride 1 gram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) Linagliptin (substance) true Inferred relationship Some 2
Product containing precisely linagliptin 2.5 milligram and metformin hydrochloride 1 gram/1 each conventional release oral tablet (clinical drug) Has presentation strength numerator unit mg true Inferred relationship Some 2
Product containing precisely linagliptin 2.5 milligram and metformin hydrochloride 1 gram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Some 2

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start